Why is NAMS Up Today?
About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: +0.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for NAMS's 8% move
No Options Available
NAMS doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get NAMS Alerts
We'll notify you when NAMS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
NAMS has moved more than 3.0% up on 40 occasions in the past year.
Frequently Asked Questions
Why is NAMS stock up today?
This stock is significantly outperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is NAMS stock a buy or sell right now?
Based on current analysis, NAMS shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the NAMS stock price target?
NAMS is currently trading at $20.66. Based on today's momentum, the expected short-term range is $20.25 - $21.28. See long-term price prediction →
Will NAMS stock continue rising?
Our analysis shows a 45% probability that NAMS's move continues in the next 1-3 days. Key level to watch: $21.70 (resistance).
Is NAMS stock oversold or overbought?
NAMS's RSI (Relative Strength Index) is currently at 50.4. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for NAMS stock?
NAMS's 10-day momentum indicator is at -0.35. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is NAMS outperforming or underperforming the market?
NAMS (+7.73%) is currently significantly outperforming the market (+6.4% vs SPY). Today, the S&P 500 (SPY) is up 1.32%, and Nasdaq (QQQ) is up 2.31%.
What does MACD indicate for NAMS?
NAMS's MACD (-0.69) is currently above the signal line (-0.78), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 18.2) is weak.
Is NAMS in an uptrend or downtrend?
Based on moving average analysis, NAMS is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $20.21, 50-day SMA: $21.75.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis